Neutralization sensitivity and accessibility of continuous B cell epitopes of the feline immunodeficiency virus envelope

Journal of General Virology

Volumn 77, Issue 4, 1996, Pages 759-771

  Richardson, J ^a   Fossati, I ^a,c   Moraillon, A ^b   Castelot, S ^a   Sonigo, P ^a   Pancino, G ^a  

^a INSTITUT COCHIN   (France)

^b ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^c Health Sciences Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MEMBRANE ANTIGEN; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANTIGEN ANTIBODY REACTION; ARTICLE; B LYMPHOCYTE; CAT; CONTROLLED STUDY; FELINE IMMUNODEFICIENCY VIRUS; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS ENVELOPE; VIRUS NEUTRALIZATION;

EID: 0029985950     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-77-4-759     Document Type: Article

References (50)

1. AVRAMÉAS. A., STROSBERG, A. D., MORAILLON, A., SONIGO, P. & PANCINO, G ( 1993). Serological diagnosis of feline immunodeficiency virus (FIV) infection based on synthetic peptides from Env glycoproteins. Research in Virology 144, 209-218.
2. BALDINOTTI, F., MATTEUCCI, D., MAZZETTI, P., GIANNELLI, C., BASDECCHI, P., TOZZINI, F. & BENDINELLI, M. (1994). Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system Journal of Virology 68, 4572-4579.
3. BRODER, C. C., EARL, P L., LONG, D., ABEDON, S. T., Moss, B. & DOMS, R. W. (1994). Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: oligomer-specific and -sensitive monoclonal antibodies. Proceedings of the National Academy of Sciences, USA 91, 11699-11703.
4. DE RONDE, A., STAM, J. G., BOERS, P., LANGEDUK, H., MELOEN, R., HESSELINK, W., LIAN, C. E., KELDERMANS, J. M., VAN VLIET, A , VERSCHOOR, E. J., HORZINEK, M. C. & EGBERINK, H. F. (1994). Antibody response in cats to the envelope proteins of feline immunodeficiency virus: identification of an immunodominant neutralization domain Virology 198, 257-264.
5. DIMMOCK, N. J. (1993). Neutralization of animal viruses. Current Topics in Microbiology and Immunology 183, 1-149.
6. EARL, P. L., BRODER, C. C., LONG, D., LEE, S. A., PETERSON, J., CHAKRABARTI, S., DOMS, R. W. & Moss, B. (1994). Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities. Journal of Virology 68, 3015-3026.
7. FEVEREIRO, M., RONEKER, C., LAUFS, A., TAVARES, L. & DE NORONHA, F. (1991). Characterization of two monoclonal antibodies against feline immunodeficiency virus gag gene products and their application in an assay to evaluate neutralizing antibody activity. Journal of General Virology 72, 617-622.
8. FONTENOT, J. D , HOOVER, E. A., ELDER, J. H. & MONTELARO, R. C. (1992). Evaluation of feline immunodeficiency virus and feline leukemia virus transmembrane peptides for serological analysis. Journal of Clinical Microbiology 30, 1885-1890.
9. FULTZ, P. N., NARA, P., BARRE-SINOUSSI, F., CHAPUT, A., GREENBURG, M. L., MUCHMORE, E., KIENY, M.-P. & GIRARD, M. (1992). Vaccine protection of chimpanzees against challenge with HIV-1 infected peripheral blood mononuclear cell. Science 256, 1687-1689.
10. GlRARD, M., KlENY, M.-P., PINTER, A., BARRE-SINOUSSI, F., NARA, P., KOLBE, H., KUSUM, K., CHAPUT, A., REINHART, T., MUCHMORE, E., RONCO, J., KACZOREK, M , GOMARD, E., GLUCKMAN, J.-C. & FULTZ, P. N. (1991). Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus. Proceedings of the National Academy of Sciences, USA 88, 542-546.
11. HO, D. D., MCKEATING, J. A., LI, X. L., MOUDGIL, T., DAAR, E. S., SUN, N.-C. & ROBINSON, J. E. (1991). Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type-1 neutralization identified by a human monoclonal antibody. Journal of Virology 65, 489-493.
12. HOHDATSU, T., PU, R., TORRES, B. A., TRUJILLO, S., GARDNER, M. B. & YAMAMOTO, J. K. (1993). Passive antibody protection of cats against feline immunodeficiency virus infection. Journal of Virology 67, 2344-2348.
13. HOMSY, J., TATENO, M. & LEVY, J. A. (1988). Antibody-dependent enhancement of HIV infection. Lancet i, 1285-1286.
14. HOMSY, J , MEYER, M., TATENO, M., CLARKSON, S. & LEVY, J. A. (1989) The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells. Science 244, 1357-1360.
15. HOSIE, M. G., OSBORNE, R., REID, G., NEIL, J. C. & JARRETT, O. (1992). Enhancement after feline immunodeficiency virus vaccination Veterinary Immunology and Immunopathology 35, 191-197.
16. HURTREL, M., GANIÈRE, J.-P., GUELFI, J.-F , CHAKRABARTI, L., MAIRE, M.-A., GRAY, F., MONTAGNIER, L. & HURTREL, B. (1992). Comparison of early and late feline immunodeficiency virus encephalopathies. AIDS 6, 399-406.
17. HUYNH, T. V., YOUNG, R A. & DAVIS, R. W. (1985). Constructing and Screening cDNA Libraries in λgt10 and λgt11, pp. 49-78. Oxford: IRL Press
18. HWANG, S. S., BOYLE, T. J., LYERLY, H. K. & CULLEN, B. R (1991). Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 253, 71-73.
19. LOMBARDI, S., GARZELLI, C., LA ROSA, C., ZACCARO, L , SPECTER, S., MALVALDI, G., TOZZINI, F., ESPOSITO, F. & BENDINELLI, M. (1993). Identification of a linear neutralization site within the third variable region of the feline immunodeficiency virus envelope. Journal of Virology 67, 4742-4749.
20. LOMBARDI, S., GARZELLI, C., PISTELLO, M , MASSI, C., MATTEUCCI, D , BALDINOTTI, F., CAMMAROTA, G., DA PRATO, L., BANDECCHI, P., TOZZINI, F. & BENDINELLI, M. (1994). A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity. Journal of Virology 68, 8374-8379.
21. LOMBARDI, S., MASSI, C., TOZZINI, F., ZACCARO, L., BAZZICHI, A., BANDECCHI, P., LA ROSA, C., BENDINELLI, M. & GARZELLI, C. (1995). Epitope mapping of the V3 domain of feline immunodeficiency virus envelope glycoprotein by monoclonal antibodies. Journal of General Virology 76, 1893-1899.
22. MASCOLA, J. R., MATHIESON, B. J., ZACK, P. M., WALKER, M. C., HALSTEAD, S. B. & BURKE, D. S. (1993). Summary report: workshop on the potential risks of antibody-dependent enhancement in human HIV vaccine trials. AIDS Research and Human Retroviruses 9, 1175-1184.
23. MOORE, J. P. & Ho, D. D. (1992). Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans. Journal of Virology 67, 863-875.
24. MOORE, J. P., CAO, Y., QING, L., SATTENTAU, Q. J., PYATI, J., KODURI, R., ROBINSON, J., BARBAS, C. F., III, BURTON, D. R. & HO, D. D. (1995) Primary isolates of human immunodeficiency virus type I are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. Journal of Virology 69, 101-109.
25. MORAILLON, A., BARRE-SINOUSSI, F., PARODI, A., MORAILLON, R. & DAUGUET, C. (1992). In vitro properties and experimental pathogenic effect of three feline immunodeficiency viruses (FIV) isolated from cats with terminal disease. Veterinary Microbiology 31, 41-54.
26. NARA, P. L., GARRITY, R. R. & GOUDSMIT, J. (1991). Neutralization of H1V-1: a paradox of humoral proportions. FASEB Journal 5, 2437-2455
27. NORRBY, E. & MATTHEWS, T. (1993). B-cell antigenic sites in the envelope proteins of primate lentiviruses and their role in vaccine development. AIDS 7, supplementum 1, 27-33.
28. OSBORNE, R., RlGBY, M., SIEBELINK, K., NEIL, J. C. & JARRETT, O. (1994). Virus neutralization reveals antigenic variation among feline immunodeficiency virus isolates. Journal of General Virology 75, 3641-3645.
29. PANCINO, G., CHAPPEY, C., SAURIN, W. & SONIGO, P. (1993). B epitopes and selection pressures in feline immunodeficiency virus envelope glycoproteins. Journal of Virology 67, 664-672.
30. PANCINO, G., CAMOIN, L. & SONIGO, P. (1995a). Structural analysis of the principal immunodominant domain of the feline immunodeficiency virus transmembrane glycoprotein. Journal of Virology 69, 2110-2118.
31. PANCINO, G., CASTELOT, S. & SONIGO, P. (1995b). Differences in feline immunodeficiency virus (FIV) host cell range correlate with envelope fusogenic properties. Virology 206, 796-806.
32. PU, R., OKADA, S., LITTLE, E. R., XU, B., STOFFS, W. V & YAMAMOTO, J. K. (1995). Protection of neonatal kittens against feline immunodeficiency virus infection with passive maternal antiviral antibodies. AIDS 9, 235-242.
33. RIGBY, M. A., HOLMES, E. C., PISTELLO, M., MACKAY, A., BROWN, A. J. L. & NEIL, J. C. (1993). Evolution of structural proteins of feline immunodeficiency virus: molecular epidemiology and evidence of selection for change. Journal of General Virology 74, 425-436.
34. ROBINSON, W. E., MONTEFIORI, D. C. & MITCHELL, W. M. (1988). Antibody-dependent enhancement of human immunodeficiency virus type 1 infection. Lancet i, 790-794
35. ROBINSON, W E., MONTEFIORI, D. C. & MITCHELL, W. M. (1990). Complement-mediated antibody-dependent enhancement of HIV-1 infection requires CD4 and complement receptors. Virology 175, 600-604.
36. SATTENTAU, Q. J. & MOORE, J. P. (1995). Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer. Journal of Experimental Medicine 182, 185-196.
37. SIEBELINK, K H. J., TIJHAAR, E., HUISMAN, R. C., HUISMAN, W., DE RONDE, A., DARBY, I. H., FRANCIS, M. J., RIMMELZWAAN, G. F. & OSTERHAUS, A. D. M. E. (1995a). Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines. Journal of Virology 69, 3704-3711.
38. SIEBELINK, K., H. J., HUISMAN, W., KARLAS, J. A., RIMMELZWAAN, G. F., BOSCH, M. L. & OSTERHAUS, A. D. M. E. (1995b). Neutralization of feline immunodeficiency virus by polyclonal feline antibody: simultaneous involvement of hypervariable regions 4 and 5 of the surface glycoprotein. Journal of Virology 69, 5124-5127.
39. SODORA, D. L., SHPAER, E. G., KITCHELL, B., DOW, S. W., HOOVER, E. A. & MULLINS, J. I. (1994). Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns. Journal of Virology 68, 2230-2238.
40. STANLEY, K. K. (1988). Producing antibodies of predetermined specificity from E. coli hybrid proteins. Methods in Molecular Biology 4, 343-349.
41. STANLEY, K. K. & LUZIO, J. P. (1984). Construction of a new family of high efficiency bacterial expression vectors: identification of cDNA clones coding for human liver proteins. EMBO Journal 3, 1429-1433.
42. SULLIVAN, N., SUN, Y., LI, J., HOFMAN, W. & SODROSKI, J. (1995). Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. Journal of Virology 69, 4413-4422.
43. TAKEDA, A., TUAZON, C. U. & ENNIS, F. A. (1988). Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science 242, 580-583.
44. TALBOTT, R. L., SPARGER, E. E., LOVELACE, K. M., FITCH, W. M., PEDERSEN, N. C., LUCIW, P. A. & ELDER, J. H. (1989). Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proceedings of the National Academy of Sciences, USA 86, 5743-5747.
45. TOZZINI, F., MATTEUCCI, D., BANDECCHI, P., BALDINOTTI, F., SIEBELINK, K., OSTERHAUS, A. & BENDINELLI, M. (1993). Neutralizing antibodies in cats infected with feline immunodeficiency virus. Journal of Clinical Microbiology 31, 1626-1629.
46. VERSCHOOR, E. J., BOVEN, L. A., BLAAK, H. & VAN VLIET, A. L. W. (1995). A single mutation within the V3 envelope neutralization domain of feline immunodeficiency virus determines its tropism for CRFK cells. Journal of Virology 69, 4752-4757.
47. VOGEL, T., KURTH, R. & NORLEY, S. (1994). The majority of neutralizing Abs in HIV-1-infected patients recognize linear V3 loop sequences. Journal of Immunology 153, 1895-1904.
48. WESTERVELT, P , GENDELMAN, H. E. & RATNER, L. (1991). Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes. Proceedings of the National Academy of Sciences. USA 88, 3097-3101.
49. WRIN, T., LOH, T. P., VENNARI, J. C., SCHUTTEMAKER, H. & NUNBERG, J. H. (1995). Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera. Journal of Virology 69, 39-48.
50. YAMAMOTO, J. K., ACKLEY, C D , ZOCHLINSKI, H., LOUIE, H., PEMBROKE, E., TORTEN, M., HANSEN, H., MUNN, R. & OKUDA, T. (1991). Development of IL-2-independent feline lymphoid cell lines chronically infected with feline immunodeficiency virus: importance for diagnostic reagents and vaccines. Intervirology 32, 361-375.